Open AccessCost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
Author(s) -
StamSlob Ma C.,
Graaf Yolanda,
Greving Jacoba P.,
Dorresteijn Jannick A.N.,
Visseren Frank L.J.
Publication year - 2017
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.116.004648
Subject(s) - medicine , coronary artery disease , quality adjusted life year , relative risk , intensive care , disease , cardiology , surgery , cost effectiveness , confidence interval , intensive care medicine , risk analysis (engineering)
A validated prediction model estimates the absolute benefit of intensive versus standard lipid-lowering therapy (LLT) with statins on next major cardiovascular events for individual patients with coronary artery disease. We aimed to assess whether targeting intensive LLT therapy to coronary artery disease patients with the highest predicted absolute benefit is cost-effective compared to treating all with standard or all with intensive LLT.